POST-GONADECTOMY HORMONE THERAPY IN MORRIS SYNDROME: STRATEGIES TO MINIMIZE SIDE EFFECTS AND MAXIMIZE QUALITY OF LIFE

Authors

  • Bianca Pedrosa Pereira
  • Pedro Fechine Honorato
  • Karoline Eyshila Sousa Araújo
  • Bruno Costa Nascimento
  • Sofia Brenda Rodrigues Silvino
  • Francisca Erika Brito da Silva
  • Maria Izabele de Oliveira Pereira
  • Luis Eufrásio Farias Neto
  • Rafaela Amaral Alves
  • Francisco Araujo Pontes

Keywords:

Morris syndrome, Hormone Therapy

Abstract

Morris Syndrome, characterized by androgen insensitivity, requires post-gonadectomy hormone therapy to maintain bone, cardiovascular, and psychological health. The integrative review highlights the importance of transdermal estrogens and clinical monitoring to minimize risks and optimize quality of life.

DOI: 10.56238/sevenVhealth2025-008

Published

2025-04-15